Patents by Inventor Shoko Yoshida
Shoko Yoshida has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11916763Abstract: A traffic monitoring apparatus includes: a header analysis circuit configured to acquire one or more identifiers from a header of a received packet; a rule registration circuit configured to convert a rule table including rules in which one or more rule elements are registered for each of the rules into a predetermined format and register the rule table in a rule matching circuit; and the rule matching circuit configured to search for rules to be matched with the acquired identifiers.Type: GrantFiled: July 1, 2019Date of Patent: February 27, 2024Assignee: Nippon Telegraph and Telephone CorporationInventors: Yuta Ukon, Shuhei Yoshida, Shoko Oteru, Namiko Ikeda, Koyo Nitta
-
Publication number: 20220106324Abstract: A compound that inhibits interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity is provided. The present invention provides a dispiropyrrolidine derivative represented by the following formula (1), which has various substituents, inhibits interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity, wherein R1, R2, R3, ring A, and ring B in formula (1) respectively have the same meanings as defined in the specification.Type: ApplicationFiled: April 19, 2021Publication date: April 7, 2022Inventors: Yuuichi SUGIMOTO, Kouichi UOTO, Takanori WAKABAYASHI, Masaki MIYAZAKI, Masaki SETOGUCHI, Toru TANIGUCHI, Keisuke YOSHIDA, Akitake YAMAGUCHI, Shoko YOSHIDA
-
Patent number: 10030030Abstract: Crystals of a dispiropyrrolidine compound or a salt thereof which inhibits the action of Mdm2 are provided. The present invention provides crystals of (3?R,4?S,5?R)—N-[(3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl]-6?-chloro-4?-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2?-oxo-1?,2?-dihydrodispiro[cyclohexane-1,2?-pyrrolidine-3?,3?-indole]-5?-carboxamide or a salt thereof which inhibits Mdm2 and has anti-tumor activity. The present invention also provides a medicament comprising the same.Type: GrantFiled: February 2, 2018Date of Patent: July 24, 2018Assignee: Daiichi Sankyo Company, LimitedInventors: Shoko Yoshida, Yuuichi Sugimoto
-
Patent number: 10023578Abstract: Crystals of a dispiropyrrolidine compound or a salt thereof which inhibits the action of Mdm2 are provided. The present invention provides crystals of (3?R,4?S,5?R)—N-[(3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl]-6?-chloro-4?-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2?-oxo-1?,2?-dihydrodispiro[cyclohexane-1,2?-pyrrolidine-3?,3?-indole]-5?-carboxamide or a salt thereof which inhibits Mdm2 and has anti-tumor activity. The present invention also provides a medicament comprising the same.Type: GrantFiled: February 2, 2018Date of Patent: July 17, 2018Assignee: Daiichi Sankyo Company, LimitedInventors: Shoko Yoshida, Yuuichi Sugimoto
-
Publication number: 20180155356Abstract: Crystals of a dispiropyrrolidine compound or a salt thereof which inhibits the action of Mdm2 are provided. The present invention provides crystals of (3?R,4?S,5?R)—N-[(3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl]-6?-chloro-4?-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2?-oxo-1?,2?-dihydrodispiro[cyclohexane-1,2?-pyrrolidine-3?,3?-indole]-5?-carboxamide or a salt thereof which inhibits Mdm2 and has anti-tumor activity. The present invention also provides a medicament comprising the same.Type: ApplicationFiled: February 2, 2018Publication date: June 7, 2018Inventors: Shoko YOSHIDA, Yuuichi SUGIMOTO
-
Publication number: 20180155355Abstract: Crystals of a dispiropyrrolidine compound or a salt thereof which inhibits the action of Mdm2 are provided. The present invention provides crystals of (3?R,4?S,5?R)-N-[(3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl]-6?-chloro-4?-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2?-oxo-1?,2?-dihydrodispiro[cyclohexane-1,2?-pyrrolidine-3?,3?-indole]-5?-carboxamide or a salt thereof which inhibits Mdm2 and has anti-tumor activity. The present invention also provides a medicament comprising the same.Type: ApplicationFiled: February 2, 2018Publication date: June 7, 2018Inventors: Shoko YOSHIDA, Yuuichi SUGIMOTO
-
Patent number: 9884871Abstract: Crystals of a dispiropyrrolidine compound or a salt thereof which inhibits the action of Mdm2 are provided. The present invention provides crystals of (3?R,4?S,5?R)—N-[(3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl]-6?-chloro-4?-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2?-oxo-1?,2?-dihydrodispiro[cyclohexane-1,2?-pyrrolidine-3?,3?-indole]-5?-carboxamide or a salt thereof which inhibits Mdm2 and has anti-tumor activity. The present invention also provides a medicament comprising the same.Type: GrantFiled: December 6, 2016Date of Patent: February 6, 2018Assignee: Daiichi Sankyo Company, LimitedInventors: Shoko Yoshida, Yuuichi Sugimoto
-
Patent number: 9745315Abstract: Crystals of a dispiropyrrolidine compound or a salt thereof which inhibits the action of Mdm2 are provided. The present invention provides crystals of (3?R,4'S,5?R)—N-[(3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl]-6?-chloro-4?-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2?-oxo-1?,2?-dihydrodispiro[cyclohexane-1,2?-pyrrolidine-3?,3?-indole]-5?-carboxamide or a salt thereof which inhibits Mdm2 and has anti-tumor activity. The present invention also provides a medicament comprising the same.Type: GrantFiled: December 6, 2016Date of Patent: August 29, 2017Assignee: Daiichi Sankyo Company, LimitedInventors: Shoko Yoshida, Yuuichi Sugimoto
-
Patent number: 9718830Abstract: Crystals of a dispiropyrrolidine compound or a salt thereof which inhibits the action of Mdm2 are provided. The present invention provides crystals of (3?R,4?S,5?R)-N-[(3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl]-6?-chloro-4?-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2?-oxo-1?,2?-dihydrodispiro[cyclohexane-1,2?-pyrrolidine-3?,3?-indole]-5?-carboxamide or a salt thereof which inhibits Mdm2 and has anti-tumor activity. The present invention also provides a medicament comprising the same.Type: GrantFiled: December 6, 2016Date of Patent: August 1, 2017Assignee: DAIICHI SANKYO COMPANY, LIMITEDInventors: Shoko Yoshida, Yuuichi Sugimoto
-
Patent number: 9718831Abstract: Crystals of a dispiropyrrolidine compound or a salt thereof which inhibits the action of Mdm2 are provided. The present invention provides crystals of (3?R,4?S,5?R)—N-[(3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl]-6?-chloro-4?-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2?-oxo-1?,2?-dihydrodispiro[cyclohexane-1,2?-pyrrolidine-3?,3?-indole]-5?-carboxamide or a salt thereof which inhibits Mdm2 and has anti-tumor activity. The present invention also provides a medicament comprising the same.Type: GrantFiled: December 6, 2016Date of Patent: August 1, 2017Assignee: DAIICHI SANKYO COMPANY, LIMITEDInventors: Shoko Yoshida, Yuuichi Sugimoto
-
Publication number: 20170081337Abstract: Crystals of a dispiropyrrolidine compound or a salt thereof which inhibits the action of Mdm2 are provided. The present invention provides crystals of (3?R,4'S,5?R)—N-[(3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl]-6?-chloro-4?-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2?-oxo-1?,2?-dihydrodispiro[cyclohexane-1,2?-pyrrolidine-3?,3?-indole]-5?-carboxamide or a salt thereof which inhibits Mdm2 and has anti-tumor activity. The present invention also provides a medicament comprising the same.Type: ApplicationFiled: December 6, 2016Publication date: March 23, 2017Inventors: Shoko YOSHIDA, Yuuichi SUGIMOTO
-
Publication number: 20170081336Abstract: Crystals of a dispiropyrrolidine compound or a salt thereof which inhibits the action of Mdm2 are provided. The present invention provides crystals of (3?R,4?S,5?R)—N-[(3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl]-6?-chloro-4?-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2?-oxo-1?,2?-dihydrodispiro[cyclohexane-1,2?-pyrrolidine-3?,3?-indole]-5?-carboxamide or a salt thereof which inhibits Mdm2 and has anti-tumor activity. The present invention also provides a medicament comprising the same.Type: ApplicationFiled: December 6, 2016Publication date: March 23, 2017Inventors: Shoko YOSHIDA, Yuuichi SUGIMOTO
-
Publication number: 20170081334Abstract: Crystals of a dispiropyrrolidine compound or a salt thereof which inhibits the action of Mdm2 are provided. The present invention provides crystals of (3?R,4?S,5?R)—N-[(3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl]-6?-chloro-4?-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2?-oxo-1?,2?-dihydrodispiro[cyclohexane-1,2?-pyrrolidine-3?,3?-indole]-5?-carboxamide or a salt thereof which inhibits Mdm2 and has anti-tumor activity. The present invention also provides a medicament comprising the same.Type: ApplicationFiled: December 6, 2016Publication date: March 23, 2017Inventors: Shoko YOSHIDA, Yuuichi SUGIMOTO
-
Publication number: 20170081335Abstract: Crystals of a dispiropyrrolidine compound or a salt thereof which inhibits the action of Mdm2 are provided. The present invention provides crystals of (3?R,4?S,5?R)-N-[(3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl]-6?-chloro-4?-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2?-oxo-1?,2?-dihydrodispiro[cyclohexane-1,2?-pyrrolidine-3?,3?-indole]-5?-carboxamide or a salt thereof which inhibits Mdm2 and has anti-tumor activity. The present invention also provides a medicament comprising the same.Type: ApplicationFiled: December 6, 2016Publication date: March 23, 2017Inventors: Shoko YOSHIDA, Yuuichi SUGIMOTO
-
Patent number: 9540386Abstract: Crystals of a dispiropyrrolidine compound or a salt thereof which inhibits the action of Mdm2 are provided. The present invention provides crystals of (3?R,4?S,5?R)-N-[(3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl]-6?-chloro-4?-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2?-oxo-1?,2?-dihydrodispiro[cyclohexane-1,2?-pyrrolidine-3?,3?-indole]-5?-carboxamide or a salt thereof which inhibits Mdm2 and has anti-tumor activity. The present invention also provides a medicament comprising the same.Type: GrantFiled: May 2, 2016Date of Patent: January 10, 2017Assignee: Daiichi Sankyo Company, LimitedInventors: Shoko Yoshida, Yuuichi Sugimoto
-
Publication number: 20160244458Abstract: Crystals of a dispiropyrrolidine compound or a salt thereof which inhibits the action of Mdm2 are provided. The present invention provides crystals of (3?R,4?S,5?R)-N-[(3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl]-6?-chloro-4?-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2?-oxo-1?,2?-dihydrodispiro[cyclohexane-1,2?-pyrrolidine-3?,3?-indole]-5?-carboxamide or a salt thereof which inhibits Mdm2 and has anti-tumor activity. The present invention also provides a medicament comprising the same.Type: ApplicationFiled: May 2, 2016Publication date: August 25, 2016Inventors: Shoko YOSHIDA, Yuuichi SUGIMOTO
-
Publication number: 20160203493Abstract: A service provider places a server at a data center and a service user searches a website, connecting a terminal to the Internet. When the service user specifies a URL in a website server via a terminal accessible to the Internet, data of content stored onto the server is read out and transmitted to the terminal of the service user. The server stores customer information received from the service user and performs a customer registration as a merchandise purchaser. After completing a customer registration, information advising a membership registration different from a customer registration is transmitted to the service user.Type: ApplicationFiled: December 14, 2015Publication date: July 14, 2016Applicants: NIKON CORPORATION, NIKON SYSTEMS INC.Inventors: Shoko YOSHIDA, Jun NAGAI, Miho SEKI, Setsu MITSUHASHI, Akira OHMURA, Takashi TOIDA
-
Patent number: 9359368Abstract: Crystals of a dispiropyrrolidine compound or a salt thereof which inhibits the action of Mdm2 are provided. The present invention provides crystals of (3?R,4?S,5?R)—N—[(3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl]-6?-chloro-4?-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2?-oxo-1?,2?-dihydrodispiro [cyclohexane-1,2?-pyrrolidine-3?,3?-indole]-5?-carboxamide or a salt thereof which inhibits Mdm2 and has anti-tumor activity. The present invention also provides a medicament comprising the same.Type: GrantFiled: September 5, 2013Date of Patent: June 7, 2016Assignee: Daiichi Sankyo Company, LimitedInventors: Shoko Yoshida, Yuuichi Sugimoto
-
Publication number: 20150210707Abstract: Crystals of a dispiropyrrolidine compound or a salt thereof which inhibits the action of Mdm2 are provided. The present invention provides crystals of (3?R,4?S,5?R)-N-[(3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl]-6?-chloro-4?-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2?-oxo-1?,2?-dihydrodispiro[cyclohexane-1,2?-pyrrolidine-3?,3?-indole]-5?-carboxamide or a salt thereof which inhibits Mdm2 and has anti-tumor activity. The present invention also provides a medicament comprising the same.Type: ApplicationFiled: September 5, 2013Publication date: July 30, 2015Inventors: Shoko Yoshida, Yuuichi Sugimoto
-
Patent number: 8975263Abstract: The present invention relates to a compound or a pharmacologically acceptable salt thereof having an excellent glucose lowering effect. A compound represented by the following general formula (I) or a pharmacologically acceptable salt thereof: wherein R1 represents a C1-C3 alkyl group, each substituent R2 may be the same or different and may each represent a C1-C3 alkyl group, R3 represents an optionally substituted pyridyl group or the like, R4 and R5, which are the same or different, each represent a C1-C3 alkyl group, R6 and R7, which are the same or different, each represent a C1-C3 alkyl group, and n represents 0 to 3.Type: GrantFiled: May 30, 2014Date of Patent: March 10, 2015Assignee: Daiichi Sankyo Company, LimitedInventors: Shigeo Yamanoi, Katsuji Kagechika, Tsuyoshi Soneda, Yuichi Ochiai, Hidenori Namiki, Fuminao Doi, Madoka Hoshino, Shoko Yoshida